Alecta Tjanstepension Omsesidigt’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350M Hold
1,393,700
1.47% 17
2026
Q1
$303M Buy
1,393,700
+49,900
+4% +$11.1M 1.48% 17
2025
Q4
$307M Buy
1,343,800
+184,900
+16% +$42.1M 1.35% 21
2025
Q3
$268M Buy
1,158,900
+110,300
+11% +$22.5M 1.2% 27
2025
Q2
$195M Hold
1,048,600
0.91% 34
2025
Q1
$220M Hold
1,048,600
1.23% 29
2024
Q4
$186M Buy
+1,048,600
New +$193M 0.98% 31

Other funds holding ABBV

Alecta Tjanstepension Omsesidigt's ABBV Position: Q2 2026 in Review

Alecta Tjanstepension Omsesidigt held its AbbVie (ABBV) position steady in Q2 2026 at 1,393,700 shares worth $350M. The position accounts for 1.47% of the portfolio, ranked #17.

Alecta Tjanstepension Omsesidigt first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Alecta Tjanstepension Omsesidigt held 1,393,700 shares of AbbVie worth $350M as of Q2 2026.
  • Alecta Tjanstepension Omsesidigt left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 1.47% of Alecta Tjanstepension Omsesidigt's portfolio in Q2 2026, its #17 holding.
  • Alecta Tjanstepension Omsesidigt first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alecta Tjanstepension Omsesidigt's 13F filing for Q2 2026, filed 23 Jul 2026.